XML 26 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Net Income (Loss) Per Common Share
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Net Income (Loss) Per Common Share
Net Income (Loss) Per Common Share
Basic and diluted net income (loss) per common share is calculated as follows (in thousands, except share and per share data):
 
Three Months Ended September 30,
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
8,142

 
$
9,338

 
$
15,638

 
$
11,374

Less: Net income (loss) attributable to noncontrolling interest
(542
)
 
(272
)
 
(3,007
)
 
(1,807
)
Net income (loss) attributable to On Deck Capital, Inc. common stockholders
$
8,684

 
$
9,610

 
$
18,645

 
$
13,181

Denominator:
 
 
 
 
 
 
 
Weighted-average common shares outstanding, basic
75,433,008

 
74,715,592

 
75,722,117

 
74,362,211

Net income (loss) per common share, basic
$
0.12

 
$
0.13

 
$
0.25

 
$
0.18

Effect of dilutive securities
2,325,273

 
4,656,899

 
2,854,782

 
3,952,508

Weighted-average common shares outstanding, diluted
77,758,281

 
79,372,491

 
78,576,899

 
78,314,719

Net income (loss) per common share, diluted
$
0.11

 
$
0.12

 
$
0.24

 
$
0.17

Anti-dilutive securities excluded
8,184,291

 
3,020,562

 
6,628,241

 
5,169,484


The difference between basic and diluted net income per common share has been calculated using the Treasury Stock Method based on the assumed exercise of outstanding stock options, the vesting of restricted stock units, or RSUs, performance restricted stock units, or PRSUs, and the issuance of stock under our employee stock purchase plan. Changes in the average market price of our stock can impact when stock equivalents are considered dilutive or anti-dilutive. For example, in periods of a declining stock price, stock equivalents have a greater likelihood of being recharacterized from dilutive to anti-dilutive. The following common share equivalent securities have been included in the calculation of dilutive weighted-average common shares outstanding:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Dilutive Common Share Equivalents
2019
 
2018
 
2019
 
2018
Weighted-average common shares outstanding
75,433,008

 
74,715,592

 
75,722,117

 
74,362,211

RSUs and PRSUs
254,262

 
1,616,072

 
562,381

 
1,083,237

Stock options
2,071,011

 
3,040,827

 
2,286,727

 
2,869,271

Employee stock purchase plan

 

 
5,674

 

Total dilutive common share equivalents
77,758,281

 
79,372,491

 
78,576,899

 
78,314,719


The following common share equivalent securities were excluded from the calculation of diluted net income per share attributable to common stockholders. Their effect would have been antidilutive for the three and nine months ended September 30, 2019 and 2018.
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019
 
2018
 
2019
 
2018
Anti-Dilutive Common Share Equivalents
 
 
 
 
 
 
 
Warrants to purchase common stock

 
22,000

 

 
22,000

RSUs and PRSUs
3,099,262

 
124,582

 
1,890,242

 
527,326

Stock options
4,498,581

 
2,840,298

 
4,151,551

 
4,586,476

Employee stock purchase plan
586,448

 
33,682

 
586,448

 
33,682

Total anti-dilutive common share equivalents
8,184,291

 
3,020,562

 
6,628,241

 
5,169,484



Our Board of Directors authorized the repurchase of up to $50 million of common stock with the repurchased shares to be retained as treasury stock and available for possible reissuance. Any share repurchases under the program will be made from time to time in the open market, in privately negotiated transactions or otherwise. The timing and amount of any share repurchases will be subject to market conditions and other factors as we may determine. The repurchase authorization expires August 31, 2020, however, we may suspend, modify or discontinue the program at any time in our discretion without prior notice. During the three months ended September 30, 2019 we repurchased 3,204,462 shares of common stock for $11.0 million.